[Pitfalls in intravesical immunotherapy of superficial carcinoma of the gallbladder with BCG vaccine].
The authors present their experience with the use of BCG immunotherapy in the treatment of superficial carcinoma of the urinary bladder in 30 patients as regards side-effects and tolerance of preparations. In the discussion they deal in particular with the classification and therapy of side-effects.
Pacík
D
D
Urologická klinika FNsP Brno-Bohunice.
Vít
V
V
Turjanica
M
M
D000283:Administration, Intravesical; D001500:BCG Vaccine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000628:therapy*; D006801:Humans; D008875:Middle Aged; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D001500:BCG Vaccine